目次

1 Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Pharmaceutical Drug Delivery Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot

2 Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation

3 Market Characteristics
3.1. Market Definition
3.2. Pharmaceutical Drug Delivery Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4 Pharmaceutical Drug Delivery Market - Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5 Macroeconomic Indicators

6 Recent Developments

7 Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends

8 Risk Analysis

9 Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological

10 Pharmaceutical Drug Delivery Market
10.1. Overview
10.2. Historical Analysis (2016-2020)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11 Pharmaceutical Drug Delivery Market Size & Forecast 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Route of Administration
11.3.1.1. Oral
11.3.1.1.1 By Value (USD Million) 2022-2032F
11.3.1.1.2 Market Share (%) 2022-2032F
11.3.1.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Injectable
11.3.1.2.1 By Value (USD Million) 2022-2032F
11.3.1.2.2 Market Share (%) 2022-2032F
11.3.1.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Topical
11.3.1.3.1 By Value (USD Million) 2022-2032F
11.3.1.3.2 Market Share (%) 2022-2032F
11.3.1.3.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Ocular
11.3.1.4.1 By Value (USD Million) 2022-2032F
11.3.1.4.2 Market Share (%) 2022-2032F
11.3.1.4.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.5. Pulmonary
11.3.1.5.1 By Value (USD Million) 2022-2032F
11.3.1.5.2 Market Share (%) 2022-2032F
11.3.1.5.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.6. Nasal
11.3.1.6.1 By Value (USD Million) 2022-2032F
11.3.1.6.2 Market Share (%) 2022-2032F
11.3.1.6.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.7. Transmucosal
11.3.1.7.1 By Value (USD Million) 2022-2032F
11.3.1.7.2 Market Share (%) 2022-2032F
11.3.1.7.3 Y-o-Y Growth (%) 2022-2032F
11.3.1.8. Implantable
11.3.1.8.1 By Value (USD Million) 2022-2032F
11.3.1.8.2 Market Share (%) 2022-2032F
11.3.1.8.3 Y-o-Y Growth (%) 2022-2032F
11.3.2. By Application
11.3.2.1. Infectious Diseases
11.3.2.1.1 By Value (USD Million) 2022-2032F
11.3.2.1.2 Market Share (%) 2022-2032F
11.3.2.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Cancer
11.3.2.2.1 By Value (USD Million) 2022-2032F
11.3.2.2.2 Market Share (%) 2022-2032F
11.3.2.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Cardiovascular Diseases
11.3.2.3.1 By Value (USD Million) 2022-2032F
11.3.2.3.2 Market Share (%) 2022-2032F
11.3.2.3.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.4. Diabetes
11.3.2.4.1 By Value (USD Million) 2022-2032F
11.3.2.4.2 Market Share (%) 2022-2032F
11.3.2.4.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.5. Respiratory Diseases
11.3.2.5.1 By Value (USD Million) 2022-2032F
11.3.2.5.2 Market Share (%) 2022-2032F
11.3.2.5.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.6. Central Nervous System Disorders
11.3.2.6.1 By Value (USD Million) 2022-2032F
11.3.2.6.2 Market Share (%) 2022-2032F
11.3.2.6.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.7. Autoimmune Diseases
11.3.2.7.1 By Value (USD Million) 2022-2032F
11.3.2.7.2 Market Share (%) 2022-2032F
11.3.2.7.3 Y-o-Y Growth (%) 2022-2032F
11.3.2.8. Others
11.3.2.8.1 By Value (USD Million) 2022-2032F
11.3.2.8.2 Market Share (%) 2022-2032F
11.3.2.8.3 Y-o-Y Growth (%) 2022-2032F
11.3.3. By Facility of Use
11.3.3.1. Hospitals
11.3.3.1.1 By Value (USD Million) 2022-2032F
11.3.3.1.2 Market Share (%) 2022-2032F
11.3.3.1.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Ambulatory Surgery Centers/Clinics
11.3.3.2.1 By Value (USD Million) 2022-2032F
11.3.3.2.2 Market Share (%) 2022-2032F
11.3.3.2.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Home Care Settings
11.3.3.3.1 By Value (USD Million) 2022-2032F
11.3.3.3.2 Market Share (%) 2022-2032F
11.3.3.3.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Diagnostic Centers
11.3.3.4.1 By Value (USD Million) 2022-2032F
11.3.3.4.2 Market Share (%) 2022-2032F
11.3.3.4.3 Y-o-Y Growth (%) 2022-2032F
11.3.3.5. Others
11.3.3.5.1 By Value (USD Million) 2022-2032F
11.3.3.5.2 Market Share (%) 2022-2032F
11.3.3.5.3 Y-o-Y Growth (%) 2022-2032F

12 North America Pharmaceutical Drug Delivery Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Route of Administration
12.3.2. By Application
12.3.3. By Facility of Use
12.4. Country
12.4.1. United States
12.4.2. Canada

13 Europe Pharmaceutical Drug Delivery Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Route of Administration
13.3.2. By Application
13.3.3. By Facility of Use
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14 Asia Pharmaceutical Drug Delivery Market Size & Forecast 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Route of Administration
14.3.2. By Application
14.3.3. By Facility of Use
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC

15 Middle East and Africa Pharmaceutical Drug Delivery Market Size & Forecast 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Route of Administration
15.3.2. By Application
15.3.3. By Facility of Use
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa

16 Latin America Pharmaceutical Drug Delivery Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Route of Administration
16.3.2. By Application
16.3.3. By Facility of Use
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America

17 Competitive Landscape
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders

18 Company Profiles
18.1. Johnson & Johnson
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3 Market Share
18.1.4.4 Recent News & Development (Last 3 Yrs.)
18.1.4.5 Executive Team
18.2. Novartis AG
18.3. Roche Holding AG
18.4. Bayer AG
18.5. 3M Company
18.6. GlaxoSmithKline Plc
18.7. Sanofi
18.8. Pfizer Inc.
18.9. Becton, Dickinson And Company
18.10. Merck & Co. Inc.
18.11. Boehringer Ingelheim
18.12. AbbVie Inc.
18.13. Boston Scientific Corporation
18.14. Amgen Inc.
18.15. IDEAYA Biosciences
18.16. Other Prominent Players

19 Appendix

20 Consultant Recommendation